|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S1
|
$118,016
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S2
|
$170,897
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S3
|
$118,875
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S4
|
$499,947
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-10S5
|
$134,220
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-10
|
$3,253,119
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Cancer and Other Mortality Risks in a Cohort of U.S. Radiologic Technologists
|
ZIA CP010133-04180
|
$580,304
|
Linet, Martha
|
DCEG (NCI)
|
|
Cancer Center Support Grant
|
3P30CA082103-18S1
|
$121,856
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-18S2
|
$155,534
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-18S3
|
$60,000
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-18S4
|
$80,100
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-18S5
|
$200,000
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-18S6
|
$152,100
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-18S7
|
$200,000
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-18S8
|
$749,207
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
4P30CA082103-18
|
$7,063,742
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA042014-27S1
|
$16,667
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-27S2
|
$46,556
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-27S3
|
$33,760
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-27S4
|
$119,533
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-27S5
|
$59,998
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-27S6
|
$113,250
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-27S7
|
$750,000
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
5P30CA042014-27
|
$2,274,288
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA091842-15S1
|
$124,686
|
EBERLEIN, TIMOTHY
|
WASHINGTON UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA091842-15S2
|
$149,999
|
EBERLEIN, TIMOTHY
|
WASHINGTON UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA091842-15S3
|
$497,258
|
EBERLEIN, TIMOTHY
|
WASHINGTON UNIVERSITY
|
|
Cancer Center Support Grant
|
5P30CA091842-15
|
$4,305,712
|
EBERLEIN, TIMOTHY
|
WASHINGTON UNIVERSITY
|
|
Cancer Center Support Grant - UT Southwestern Medical Center
|
3P30CA142543-07S1
|
$200,000
|
COBB, MELANIE
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Cancer Center Support Grant - UT Southwestern Medical Center
|
5P30CA142543-07
|
$2,479,396
|
COBB, MELANIE
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Clinical Studies of the Molecular Genetic Basis of Kidney Cancer
|
ZIA BC 011028
|
$515,435
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Consolidated Basic Cancer Research Program
|
3P30CA010815-47S1
|
$142,498
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Consolidated Basic Cancer Research Program
|
5P30CA010815-47
|
$2,645,581
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
DEFINING RISK FACTORS FOR NF1-OPTIC GLIOMA
|
1R01CA214146-01A1
|
$348,844
|
GUTMANN, DAVID
|
WASHINGTON UNIVERSITY
|
|
DNA Repair in Human Cancer-Prone Genetic Diseases
|
ZIA BC 004517
|
$1,020,805
|
Kraemer, Kenneth
|
CCR (NCI)
|
|
Families at high risk of cancer
|
ZIA CP004410-08285
|
$198,789
|
Caporaso, Neil
|
DCEG (NCI)
|
|
Flow Cytometric Detection of Malignant Cells in Body Fluids
|
ZIC BC 011093
|
$159,113
|
Stetler-Stevenson, Maryalice
|
CCR (NCI)
|
|
Functional Analysis of the BAP1 Metastasis Suppressor Gene in Uveal Melanoma
|
4R01CA163761-05
|
$394,250
|
RAUSCHER, FRANK
|
WISTAR INSTITUTE
|
|
Genome-edited uveal melanoma cell lines for investigating constitutively active GNAQ and GNA11
|
1R03CA202316-01
|
$78,000
|
WEDEGAERTNER, PHILIP
|
THOMAS JEFFERSON UNIVERSITY
|
|
Hereditary cancer predisposition syndromes and uveal melanoma
|
5R21CA191943-02
|
$167,475
|
ABDEL-RAHMAN, MOHAMED
|
OHIO STATE UNIVERSITY
|
|
HIV/HPV Cancer Prevention, Treatment & Pathogenesis: Rwanda/Einstein Consortium
|
5U54CA190163-03
|
$732,311
|
ANASTOS, KATHRYN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Identifying a nodal point for G alpha q signaling in eye disease
|
1R01CA202778-01
|
$340,838
|
LI, DEAN
|
UNIVERSITY OF UTAH
|
|
IMMUNOLOGICAL MODULATION OF OCULAR TUMOR METASTASES
|
4R01CA030276-34
|
$282,171
|
NIEDERKORN, JERRY
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Immunotherapy Strategies for Uveal Melanoma
|
ZIA BC 010649
|
$418,046
|
Kammula, Udai
|
CCR (NCI)
|
|
Improving the Clinical Effectiveness and Understanding of the Biophysical Basis
|
5U19CA021239-37
|
$1,912,533
|
HONG, THEODORE
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Mechanisms of Action for KCN1 in the Control of Uveal Melanoma Metastasis
|
3R01CA176001-03S1
|
$48,411
|
GROSSNIKLAUS, HANS
|
EMORY UNIVERSITY
|
|
Mechanisms of Action for KCN1 in the Control of Uveal Melanoma Metastasis
|
5R01CA176001-03
|
$323,700
|
GROSSNIKLAUS, HANS
|
EMORY UNIVERSITY
|
|
Mechanisms of Cross-talk Between EphrinB and Alternate Signaling Pathways
|
ZIA BC 010006
|
$469,706
|
Daar, Ira
|
CCR (NCI)
|
|
Molecular Genetics of Melanoma
|
5K24CA149202-07
|
$172,041
|
TSAO, HENSIN
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Molecular Therapeutics of Kidney Cancer: VHL Gene and Fumarate Hydratase Gene
|
ZIA BC 011038
|
$1,030,869
|
Linehan, W. Marston
|
CCR (NCI)
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|